Adoptive Cellular Therapy (Children'S National Research Institute)

N/A

Report date: 2026/03/11 20:02:12

Base Information

Drug NameAdoptive Cellular Therapy (Children'S National Research Institute)
Drug Alias Namemulti-tumor antigen specific cytotoxic T lymphocytes (TSA-T) therapy(Children'S National Research Institute)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsTeratomaPinealomaMedulloblastoma +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChildren'S National Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesChildren'S National Research Institute
Inactive CompaniesN/A
Active IndicationsTeratomaPinealomaMedulloblastoma +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A